Will Specialty Pharmacies Become the New Norm in the Future?

Achilles Alon, PharmD, RPh, Director of Specialty Pharmacy, Co-owner of ACE-Rx Specialty Pharmacy, discusses the potential for specialty pharmacies to become the norm.




 
Transcript: That’s inevitable. It’s pretty close to that, I think, already. I think the number of specialty drugs that will—I think the amount of spend in [specialty] pharmacy in 2019 is expected to be over 50% of the spend in pharmacy in general. So, just by looking at these numbers, it’s hard to say that specialty pharmacy is not here to stay.
 

Most Popular

Related Articles

Ron Lanton III, Esq., executive director and senior counsel for Frier Levitt Government Affairs, discusses the need for increased pharmacy benefit manager regulation on a federal level.
Researchers have determined that many potentially adverse effects are not present on fact-based health care reviews.
The economics of one and done gene therapies dictate a revenue model that requires outcomes-based risk.
Company Profile >
Industry Guide >
Market News >
Peer Exchange >
Conferences >
Subscribe >
Specialty Times Resources
About Us
Advertise
Careers
Contact Us
Terms & Conditions
Privacy
MJH Associates >
Pharmacy Times
OTCGuide
American Journal of Managed Care
Cure
MD Magazine
ONCLive
Targeted Oncology
Physicians' Education Resource
Pharmacy & Healthcare Communications, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright Specialty Pharmacy Times 2006-2018
Pharmacy & Healthcare Communications, LLC. All Rights Reserved.
 

$vacMongoViewPlus$